======= FUCA2 ======= == Gene Information == * **Official Symbol**: FUCA2 * **Official Name**: alpha-L-fucosidase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2519|2519]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BTY2|Q9BTY2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FUCA2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FUCA2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/136820|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a plasma alpha-L-fucosidase, which represents 10-20% of the total cellular fucosidase activity. The protein is a member of the glycosyl hydrolase 29 family, and catalyzes the hydrolysis of the alpha-1,6-linked fucose joined to the reducing-end N-acetylglucosamine of the carbohydrate moieties of glycoproteins. This enzyme is essential for Helicobacter pylori adhesion to human gastric cancer cells. [provided by RefSeq, Aug 2010]. * **UniProt Summary**: Alpha-L-fucosidase is responsible for hydrolyzing the alpha-1,6-linked fucose joined to the reducing-end N- acetylglucosamine of the carbohydrate moieties of glycoproteins. |Alpha L fucos| |alpha-L-fucosidase activity| |regulation of entry of bacterium into host cell| |glycoside catabolic process| |fucose metabolic process| |glycoside metabolic process| |glycosyl compound catabolic process| |azurophil granule lumen| |glycosyl compound metabolic process| |hexose metabolic process| |carbohydrate derivative catabolic process| |monosaccharide metabolic process| |regulation of symbiosis, encompassing mutualism through parasitism| |lysosome| |endoplasmic reticulum lumen| |post-translational protein modification| |carbohydrate metabolic process| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |response to bacterium| |regulated exocytosis| |leukocyte mediated immunity| |regulation of multi-organism process| |exocytosis| |leukocyte activation| |secretion by cell| |carbohydrate derivative metabolic process| |export from cell| |cell activation| |immune effector process| |secretion| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |extracellular space| |small molecule metabolic process| |organic substance catabolic process| |immune response| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-1.8| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.525| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9120 * **Expression level (log2 read counts)**: 2.53 {{:chemogenomics:nalm6 dist.png?nolink |}}